171
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Clinicopathological Analysis and Demographic Features of Ocular Malignancies

ORCID Icon, ORCID Icon, , , , , , & show all
Pages 357-365 | Published online: 29 Jan 2021

References

  • Maurya RP, Bhatia RP, Jain RK, Maurya OPS. Ocular manifestations of the tumors of the paranasal sinuses and nasopharynx. Ann Ophthalmol Glaucoma. 1996;28(4):254–257.
  • Eagle RC Jr The pathology of ocular cancer. Eye (Lond). 2013;27(2):128–136. doi:10.1038/eye.2012.237
  • Aerts I, Lumbroso-le Rouic L, Gauthier-Villars M, Brisse H, Doz F, Desjardins L. Retinoblastoma. Orphanet J Rare Dis. 2006;1:31. doi:10.1186/1750-1172-1-31
  • Kaliki S, Bothra N, Bejjanki KM, et al. Malignant eyelid tumors in India: a study of 536 Asian Indian patients. Ocul Oncol Pathol. 2019;5(3):210–219. doi:10.1159/000491549
  • Koopman JH, van der Heiden-van der Loo M, van Dijk MR, Bijlsma WR. Incidence of primary malignant orbital tumours in the Netherlands. Eye (Lond). 2011;25(4):461–465. doi:10.1038/eye.2011.9
  • Shields CL, Shields JA, Peggs M. Tumors metastatic to the orbit. Ophthalmic Plast Reconst Surg. 1988;4(2):73–80. doi:10.1097/00002341-198804020-00003
  • Yildiz D, Maden G, Özturan SG, et al. A metastatic tumor of Ewing’s sarcoma in the orbit. Trends Ophthalmol. 2018;1(5). doi:10.32474/TOOAJ.2018.01.000123
  • Al-Mujaini A, Sabt B, Al-Hamdani A. Ocular sebaceous carcinoma: the great masquerader. Oman Med J. 2009;24(3):226–227. doi:10.5001/omj.2009.46
  • Misra S, Patil K, Misra N, Tandon A. Epidemiological study and treatment outcome of primary ocular and adnexal malignancies in a rural Indian tertiary eye care center. Niger J Ophthalmol. 2016;24(2):67–70. doi:10.4103/0189-9171.195197
  • Lee SB, Au Eong KG, Saw SM, Chan TK, Lee HP. Eye cancer incidence in Singapore. Br J Ophthalmol. 2000;84(7):767–770. doi:10.1136/bjo.84.7.767
  • Thakur SK, Sah SP, Lakhey M, Badhu BP. Primary malignant tumours of eye and adnexa in Eastern Nepal. Clin Exp Ophthalmol. 2003;31(5):415–417. doi:10.1046/j.1442-9071.2003.00688.x
  • Parashkevova B, Balabanov C, Stateva D. Orbital tumors: clinical cases presentation. J Int Med Assoc Bulgaria. 2007;13(1):47–50.
  • Poso MY, Mwanza JC, Kayembe DL. Malignant tumors of the eye and adnexa in Congo-Kinshasa. J Fr Ophtalmol. 2000;23(4):327–332.
  • Malik MO, El Sheikh EH. Tumors of the eye and adnexa in the Sudan. Cancer. 1979;44(1):293–303. doi:10.1002/1097-0142(197907)44:1<293::aid-cncr2820440150>3.0.co;2-r
  • Verma N, Murthy DP, Kerek A. Orbital malignancy in Papua New Guinea: A 21 year review. Aust N Z J Ophthalmol. 1999;27(1):27–31. doi:10.1046/j.1440-1606.1999.00156.x
  • Ni Z. Histopathological classification of 3510 cases with eyelid tumor. Zhonghua Yan Ke Za Zhi. 1996;32(6):435–437.
  • Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989;33(6):477–490. doi:10.1016/0039-6257(89)90049-0
  • Zurher M, Hintschich C, Gamer A, Bunce C, Collin J. Sebaceous carcinoma of the eyelid: a clinicopathological stydy. Br J Ophthalmol. 1998;82(9):1049–1055. doi:10.1136/bjo.82.9.1049
  • Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors: a retrospective study of 5504 cases and review of literature. Am J Dermatopathol. 2009;31(3):256–262. doi:10.1097/DAD.0b013e3181961861
  • Marshall EC. Epidemiology of tumors affecting the visual system. Optom Clin. 1993;3(3):1–16.
  • Maurya RP, Bhushan P, Singh VP, et al. Clinico-pathological response of neoadjuvant chemotherapy in advance ocular carcinoma. World J Surg Med Radiat Oncolol. 2012;1:25–31.
  • Wali U, Al-Mujaini A. Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol. 2010;3(3):117–121. doi:10.4103/0974-620X.71885